As of today, mobile units in villages of B.. Of Greece – Unvaccinated 60% in several regional units – The vaccination sprint of Crete
With the example of the vaccination campaign in Crete and the speed that "Eleftheria" developed through targeted actions during the two months of August-September, achieving an increase in the percentage of vaccinated residents up to 17%, The first phase of its intensification starts today from the Ministry of Health vaccination program in Northern Greece.
The head of "Eleftheria" is the general secretary of Primary Care (ΠΦΥ), K. Marios Themistocleous will visit areas of Macedonia and Thrace and will hold meetings with health professionals as well as with bodies of the Region and the Local Government, with the aim of mobilizing forces to build the wall of immunity against Covid-19 disease.
With about 60% of the population unvaccinated in several Regional units (ΠΕ) of the area but also the vaccination coverage to barely exceed 50% of the population in the metropolitan region of Thessaloniki, Efforts to increase the number of people vaccinated against coronavirus and covid-19 infection seem to be a one-way street for health authorities. Pieria, Kilkis and Xanthi are the stations of the Mobile Vaccination Units today, Drama and Pella tomorrow and Florina and Serres on Thursday. In all IPs the units will visit remote villages.
Almost all of them are hospitalized in the hospitals of Macedonia and Thrace four out of ten patients with covid-19 of the country, in the vast majority of them unvaccinated, and also the price of the epidemic in human lives remains heavy. The 50% of patients who end up every day in the last weeks comes from health formations in northern Greece, expected according to experts with the vaccine "black hole" that has opened in the area. It is characteristic that new appointments for vaccination in most areas of northern Greece have not been planned for a long time.
In total, the dead throughout the epidemic in northern Greece have outgrown them 6.500, with the highest number recorded during the second epidemic wave last winter (where the vaccine was not yet available) and during the last wave, which has been described by experts as a "wave of the unvaccinated" (severely affects those who have not been vaccinated against coronavirus).
Low vaccination coverage will cause the epidemic to resurface in the areas in question, the professor also pointed out, K. Sotiris Tsiodras speaking recently during an event at the Academy of Athens. Mr.. Tsiodras referred to the warnings of the European Center for Disease Prevention (ECDC) for an expected outbreak of pandemic in areas with low vaccination coverage, emphasizing that "The higher the vaccination coverage, the lower the number of hospitalizations and deaths ".
In northern Greece the rates of vaccination coverage only cause anxiety for the course of the epidemic and for the duration of the resurgence. Indicatively, in Kilkis is unvaccinated 58,4%, in Pieria the 57,7% of the population, in Drama 56,8%, in Xanthi 54,2%, in Serres the 53,6%, in Halkidiki and Florina 52,3%.
The vaccination rates were also low Crete at the beginning of last August. The Rethymnon PE claimed a negative "performance" with 37,6% of its population vaccinated, percentage that today has reached 53,3%. The PE of Chania from 41,2% went up to 54,5% of vaccination coverage, the PE of Heraklion from 42,5% in the 58,07% and the PE of Lassithi from 46,1% in the 59,4%.
The mobilization for "Freedom" of health and self-government is considered to give impetus to the vaccination campaign. However, in northern Greece there does not seem to be any disposition for such mobilization on the part of the priests, despite its strict recommendations Church of Greece.
However, on his part the person in charge, K. Themistocleous appealed to the residents of these areas to go to the units and discuss with the experts their possible reservations. "We invite the unvaccinated citizens and the residents of these areas to visit the Mobile Units, even if they do not want to be vaccinated. The medical staff will be there, so that he can talk to them, to solve any questions they have and it is their own decision whether they want to be vaccinated or not " he said during yesterday's briefing on "Eleftheria" at the Ministry of Health.
The course of "Freedom" in the territory
Now in Greece more than 6.500.000 citizens with at least one installment, number corresponding to a percentage 62% of the general population and in 71,3% of the adult population. The corresponding average in the European Union for citizens vaccinated with at least one dose is 68,3% of the general population and 79,9% of the adult population.
More than 6.250.000 citizens have completed their vaccination, number corresponding to a percentage 59,5% of the general population and in 69% on the adult population. The corresponding average in the European Union with integrated vaccinations is 63,2% of the general population and 74,3% of the adult population.
The last ten days 50.500 citizens have made first-date appointments. They have been vaccinated with a third dose 120.000 citizens and others 50.000 have made an appointment to be vaccinated.
They have been submitted to the bed rest vaccination program 12.000 vaccination applications and have already been vaccinated 10.000 individuals, mainly by Mobile Groups of Health Centers. From private doctors and polyclinics, have happened 2.765 vaccinations, 890 in clinics and 1.875 at home.
Improves the therapeutic quiver against Covid
Application for emergency antiviral pill authorization raises hope for covid-19 infection, filed with the US Food and Drug Administration (FDA) the pharmaceutical company Merck (MSD Greece is its name in our country).
The request of the American company was submitted after the very good data of the third phase clinical trials, which showed that the drug (name molnupiravir) reduced by about 50% hospitalization or death rate in adult patients with mild to moderate Covid symptoms. It is noted that the "molnupiravirPrevents the virus from reproducing and, Consequently, to spread to vital parts of the human body.
"The great impact of this pandemic requires that we proceed with urgent procedures, and this is what our teams did by submitting this application for molnupiravir to the FDA within 10 days after receipt of data from clinical trials ", said Merck CEO, Robert Davis.
Merck and Ridgeback Biotherapeutics, reported that in the first results of their study, Patients receiving molnupiravir within five days of the onset of Covid-19 symptoms, showed reduced by 50% hospitalization and death rate from those who received the placebo.
The study was conducted in 775 adults with mild to moderate Covid-19 symptoms who were at risk of becoming seriously ill, due to health problems, like the obesity, diabetes or heart disease.